Search results
Pfizer lifts profit view on cost cuts, demand for COVID products
Reuters· 6 days agoSales of Padcev, a treatment for advanced bladder cancer Pfizer gained through its $43 billion deal...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via Yahoo Finance· 5 days ago...Massachusetts-based biopharmaceutical company said its sales decline “aligns with the anticipated...
Pfizer profits drop on lower Covid-19 product sales
AFP via Yahoo Finance· 6 days agoPfizer reported a drop in profits on lower sales of Covid-19 related profits Wednesday as it steers investments to other pharmaceutical areas and...
Pfizer Inc (PFE) Q1 2024 Earnings: Adjusted EPS Surpasses Expectations Amidst Revenue Decline
GuruFocus.com via Yahoo Finance· 6 days agoStrategic and Operational Highlights Despite the challenges posed by declining COVID-19 product...
Pfizer Stock Jumps On 'Massive' Upside Thanks To Paxlovid Surprise
Investor's Business Daily· 6 days agoComirnaty, the Covid vaccine Pfizer developed with BioNTech (BNTX) brought in $354 million in sales,...
Q&A: AstraZeneca's COVID-19 vaccine and blood clots—what you need to know
Medical Xpress· 6 days agoPharmaceutical giant AstraZeneca admitted in court this week that its COVID-19 vaccine can cause a...
BioNTech Revenue Falls Sharply on Reduced Covid Vaccine Sales
Barrons.com· 2 days agoFEATURE U.S.-listed shares of BioNTech were falling Monday after the German company that partnered...
Supreme Court rejected military chaplains' lawsuit saying their careers were ruined after refusing...
Business Insider· 6 days agoThe Supreme Court denied military chaplains' lawsuit claiming retaliation for refusing the COVID-19 ...
COVID Vaccine Side Effects: 4 Takeaways From Our Investigation
The New York Times via Yahoo News· 4 days agoThey prevented about 14.4 million deaths worldwide, according to one estimate. In a small percentage...
Leerink Partnrs Comments on Pfizer Inc.’s Q2 2024 Earnings (NYSE:PFE)
ETF DAILY NEWS· 21 hours agoPfizer Inc. (NYSE:PFE – Free Report) – Stock analysts at Leerink Partnrs upped their Q2 2024 earnings estimates for Pfizer in a report issued on Thursday ...